drugset / Trial / NCT03631602

Posaconazole vs Itraconazole in Preventing IFD Post-HSCT

NCT03631602

Phase 2/3 Unknown 120 enrolled Fujian Medical University
RandomizedParallel-groupOpen-labelTreatment

Summary

Invasive Fungal Disease (IFD) after haematopoietic stem cell transplantation (HSCT) remain a clinical challenge.The studay aims to compare the efficacy and safety of posaconazole oral suspension vs itraconazole oral solution in preventing IFD post-HSCT.

Timeline

Start
2017-10-01
Primary completion
2019-10-01
Completion
2020-04-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Itraconazole Small molecule Oral
Subject Posaconazole Small molecule Oral